Hirtle Callaghan & CO LLC Abbott Laboratories Transaction History

Hirtle Callaghan & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $475,544 - $574,780	-4,659 Reduced 22.7%	15,866 $1.72 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $1.85 Million - $2.26 Million	16,247 Added 379.78%	20,525 $2.43 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $494,237 - $605,165	4,278 New	4,278 $602,000
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $42,711 - $51,638	-645 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $42,286 - $47,904	645 New	645 $47,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Hirtle Callaghan & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Hirtle Callaghan & CO LLC with notifications on news.